Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy? release_es5eqecocfgsxiqqgnebkma27m

by D. Gareth Evans, Sacha J. Howell, Anthony Howell

Published in Familial Cancer by Springer Science and Business Media LLC.

Volume 18, Issue 4 p377-379 (2019)

Archived Files and Locations

application/pdf  506.2 kB
file_vqkkcktozzb6pe4buc6tlttm6q (webarchive) (publisher)
Read Archived PDF
Type  article-journal
Stage   published
Date   2019-08-23
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registery
ISSN-L:  1389-9600
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 5b4e8eb3-3adf-4289-b541-f48d971bd5ab